Pre-Existing Serotonergic Pathways Guide the Navigation of Developing Serotonergic Axons

The serotonergic system originates from a small population of brainstem neurons whose axons form one of the most extensive projection networks in the vertebrate nervous system. Although a number of molecular regulators of serotonergic development have been identified, the core principles that organize this widespread axonal architecture remain poorly understood. Classical neuroanatomical studies have proposed that serotonergic axons may navigate by growing along pre-existing fiber tracts, a process termed epiphytic guidance, but this hypothesis has remained largely untested. Here, we used organotypic transplantation assays to investigate how embryonic serotonergic axons navigate within developing and adult neural tissue. Rostral raphe explants from Tph2-GFP embryos were grafted onto embryonic hindbrain flat-mounts or adult brain slices, allowing donor-derived axons to be visualized in relation to genetically labelled endogenous serotonergic pathways and host tissue architecture. Across different grafting configurations, developmental stages, and both homotopic and heterotopic host territories, donor-derived axons consistently aligned with pre-existing serotonergic pathways adopting local trajectories rather than growing independently of them. This substrate-dependent behavior extended to adult tissue, where transplanted embryonic axons preferentially followed pre-existing serotonergic axon directions. These observations reveal substantial navigational plasticity and indicate that axonal and tissue architectures can provide permissive and potentially instructive substrates for the dispersal of serotonergic fibers. Together, our findings provide experimental support for epiphytic guidance and suggest that serotonergic pathway assembly relies, at least in part, on a pioneer-follower mechanism of progressive self-scaffolding. Such a strategy may help explain how a small population of raphe neurons generates an extensive and spatially coherent neuromodulatory system.